COVID

Vials with medication and syringe on blue methacrylate table. Horizontal composition. Top elevated view.
May 11, 2023

Should I get a second bivalent COVID-19 booster?

By VUMC News and Communications
April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.

By Leigh MacMillan
Wesley Self, MD, MPH
April 11, 2023

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.

By Nancy Humphrey
April 11, 2023

COVID on Twitter: town vs. country

A natural language processing analysis of 407 million tweets from May 2020 to January 2022 captures the rural-urban divide regarding COVID-19.

By Paul Govern
April 10, 2023

Updated COVID-19 infection prevention guidelines for all VUMC workforce members

April 10, 2023

Updated guidance on masking, COVID-19 testing at VUMC

By VUMC News and Communications
April 6, 2023

COVID-19’s lingering impact on health

A decline in cardiovascular fitness — measured by activity trackers in the All of Us research program — persisted among some groups even after COVID-related restrictions were relaxed, exacerbating health disparities.
By Bill Snyder
March 30, 2023

One Hundred Oaks COVID-19 vaccination site to close April 7

The COVID-19 vaccination site at Vanderbilt Health One Hundred Oaks will close on April 7.
By VUMC News and Communications
March 23, 2023

COVID-19 vaccination site at One Hundred Oaks to close April 7

By Wayne Wood
March 23, 2023

Crowe’s research honored

Vanderbilt's James Crowe Jr., MD, was among those to receive 2023 Advocacy Awards from Research!America at the biomedical research advocacy organization’s annual awards program in Washington, D.C.
By VUMC News and Communications
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.
By Bill Snyder
February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.
By Sarah E. Glass
January 26, 2023

Study to explore COVID’s impact on essential workers

Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.
By Jill Clendening
1 2 3 4 … 40